Until relatively recently, the staging was strictly based on anatomical disease extension, whereas it now includes conventional biomarkers such as estrogen receptors (ER), progesterone receptors (PR), HER2, ki-67, and histological grade (Table 1), as well as the molecular and gene profile of the tumour itself. The gene discussed is ESR1; the disease is neoplasm.